Your browser doesn't support javascript.
loading
Refining success of cardiac resynchronization therapy using a simple score predicting the amount of reverse ventricular remodelling: results from the Markers and Response to CRT (MARC) study.
Maass, Alexander H; Vernooy, Kevin; Wijers, Sofieke C; van 't Sant, Jetske; Cramer, Maarten J; Meine, Mathias; Allaart, Cornelis P; De Lange, Frederik J; Prinzen, Frits W; Gerritse, Bart; Erdtsieck, Erna; Scheerder, Coert O S; Hill, Michael R S; Scholten, Marcoen; Kloosterman, Mariëlle; Ter Horst, Iris A H; Voors, Adriaan A; Vos, Marc A; Rienstra, Michiel; Van Gelder, Isabelle C.
Afiliação
  • Maass AH; Department of Cardiology, Thoraxcenter, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700RB Groningen, The Netherlands.
  • Vernooy K; Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Wijers SC; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van 't Sant J; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Cramer MJ; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Meine M; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Allaart CP; Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands.
  • De Lange FJ; Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands.
  • Prinzen FW; Department of Physiology, University of Maastricht, Maastricht, The Netherlands.
  • Gerritse B; Medtronic Bakken Research Center, Maastricht, The Netherlands.
  • Erdtsieck E; Center for Translational Molecular Medicine, Utrecht, The Netherlands.
  • Scheerder COS; Medtronic Bakken Research Center, Maastricht, The Netherlands.
  • Hill MRS; Currently Employed by Medtronic Trading NL, Eindhoven, The Netherlands.
  • Scholten M; Medtronic Inc, Minneapolis, MN, USA.
  • Kloosterman M; Thoraxcenter Twente, Medisch Spectrum Twente, Enschede, The Netherlands.
  • Ter Horst IAH; Department of Cardiology, Thoraxcenter, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700RB Groningen, The Netherlands.
  • Voors AA; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Vos MA; Department of Cardiology, Thoraxcenter, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700RB Groningen, The Netherlands.
  • Rienstra M; Department of Medical Physiology, University of Utrecht, Hanzeplein 1, 9700RB Groningen, Utrecht, The Netherlands.
  • Van Gelder IC; Department of Cardiology, Thoraxcenter, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700RB Groningen, The Netherlands.
Europace ; 20(2): e1-e10, 2018 02 01.
Article em En | MEDLINE | ID: mdl-28339818
ABSTRACT

Aims:

Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in systolic heart failure patients with ventricular conduction delay. Variability of individual response to CRT warrants improved patient selection. The Markers and Response to CRT (MARC) study was designed to investigate markers related to response to CRT. Methods and

results:

We prospectively studied the ability of 11 clinical, 11 electrocardiographic, 4 echocardiographic, and 16 blood biomarkers to predict CRT response in 240 patients. Response was measured by the reduction of indexed left ventricular end-systolic volume (LVESVi) at 6 months follow-up. Biomarkers were related to LVESVi change using log-linear regression on continuous scale. Covariates that were significant univariately were included in a multivariable model. The final model was utilized to compose a response score. Age was 67 ± 10 years, 63% were male, 46% had ischaemic aetiology, LV ejection fraction was 26 ± 8%, LVESVi was 75 ± 31 mL/m2, and QRS was 178 ± 23 ms. At 6 months LVESVi was reduced to 58 ± 31 mL/m2 (relative reduction of 22 ± 24%), 130 patients (61%) showed ≥ 15% LVESVi reduction. In univariate analysis 17 parameters were significantly associated with LVESVi change. In the final model age, QRSAREA (using vectorcardiography) and two echocardiographic markers (interventricular mechanical delay and apical rocking) remained significantly associated with the amount of reverse ventricular remodelling. This CAVIAR (CRT-Age-Vectorcardiographic QRSAREA -Interventricular Mechanical delay-Apical Rocking) response score also predicted clinical outcome assessed by heart failure hospitalizations and all-cause mortality.

Conclusions:

The CAVIAR response score predicts the amount of reverse remodelling after CRT and may be used to improve patient selection. Clinical Trials NCT01519908.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Europace Assunto da revista: CARDIOLOGIA / FISIOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Europace Assunto da revista: CARDIOLOGIA / FISIOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda